Novartis AG (NOVN) CHF50 (regd)

Sell:114.08 CHFBuy:114.12 CHFPrice increased0.02 CHF (0.02%)

Prices delayed by at least 15 minutes
Sell:114.08 CHF
Buy:114.12 CHF
Change:Price increased0.02 CHF (0.02%)
Deal now
Prices delayed by at least 15 minutes
Sell:114.08 CHF
Buy:114.12 CHF
Change:Price increased0.02 CHF (0.02%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open110.00 CHF
Previous close114.08 CHF
Market capCHF 232.34bn
P/E ratio19.15
Volume3,136,037
Dividend yield3.24%
EMS-

Company information

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic ...

  • LocationSwitzerland
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyCHF
  • Shares in issue2.03bn
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per shareCHF 3.70
  • Ex-dividend date10 March 2026
  • Payment date12 March 2026

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.